Filing Details

Accession Number:
0001209191-15-050701
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-05 17:25:20
Reporting Period:
2015-06-03
Filing Date:
2015-06-05
Accepted Time:
2015-06-05 17:25:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1459266 Zs Pharma Inc. ZSPH Pharmaceutical Preparations (2834) 263305698
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1198321 Farah Champsi One Embarcadero Center, Suite 3700
San Francisco CA 94111
No No Yes No
1198325 Daniel Janney One Embarcadero Center, Suite 3700
San Francisco CA 94111
No No Yes No
1198330 P Guy Nohra One Embarcadero Center, Suite 3700
San Francisco CA 94111
Yes No Yes No
1399763 Alta Partners Viii, L.p. One Embarcadero Center, Suite 3700
San Francisco CA 94111
No No Yes No
1399894 Alta Partners Management Viii, Llc One Embarcadero Center, Suite 3700
San Francisco CA 94111
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-06-03 23,189 $56.60 2,910,478 No 4 S Direct
Common Stock Disposition 2015-06-04 39,495 $57.21 2,870,983 No 4 S Direct
Common Stock Disposition 2015-06-04 48,913 $57.71 2,822,070 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $56.50 - $56.76, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
  2. These shares were sold by Alta Partners VIII, L.P. ("APVIII"), the holder of record of the securities. Alta Partners Management VIII, LLC ("APMVIII") is the general partner of APVIII. Guy Nohra, Daniel Janney and Farah Champsi are managing directors of APMVIII and exercise shared voting and investment power with respect to the shares owned by APVIII. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein. Mr. Nohra is also a director of the issuer.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $56.50 - $57.50, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $57.51 - $58.00, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.